Beyond X-Ray

AISpiration olfactory sensor products and services have been developed to detect lung cancer as early as possible through VOCs data, sensor array, and AI algorithms.

Get Started Ask a question

Beyond X-Ray

Early Lung Cancer Diagnosis using Exhaled breath

Development of early diagnosis system for lung cancer based on sensor array and artificial intelligence using exhaled VOCs.

Use as an on-site diagnostic lung cancer early screening device.

  • Upgrade in Devices and Deep Learning technologies
  • Increasing number of clinical cases in hospital
AI + Respiration

AI + Respiration

AISpiration

AISpiration is an ETRI-research institute startup where the Electronics and Telecommunications Research Institute (ETRI) is a Korean government-funded research institution in Korea. ETRI has invested exhaled breath-based E-nose technology for mobile healthcare and developed biomarkers-based healthcare devices. Seoul National University Bundang Hospital (SNUH) conducted clinical trials on lung cancer patients.

AISpiration stands on two giants shoulders and continue to innovate healthcare industry by introducing accurate and convenient healthcare products and services based on big data and AI deep learning technology.

Download corporate brochure .

Interests
  • Artificial Intelligence
  • Sensors
  • Lung Cancers
  • Data Science

Core Competency

Sensor

70%

Healthcare

70%

Artificial Intelligence

90%

History

 
 
 
 
 
Established
AISpiration Inc.
Established
Aug 2021 – Aug 2021 Seoul, South Korea

R&D:

  • Artificial Intelligence from R
  • Healthcare from SNUH
  • Sensors from ETRI
 
 
 
 
 
ETRI Laboratory Inc.
Dec 2021 – Present Daejeon, South Korea
Become ETRI laboratory company

Recent Posts

Projects

MSIT, NRF, ETRI

*
Open Statistics Package

Open Statistics Package

Digital divide solution through open source statistics software.

Contact